CytoMed Therapeutics
GDTC
#10301
Rank
NZ$18.99 M
Marketcap
NZ$1.62
Share price
-0.93%
Change (1 day)
-59.69%
Change (1 year)

Market capitalization of CytoMed Therapeutics (GDTC)

Market cap: NZ$18.99 Million

As of January 2026 CytoMed Therapeutics has a market cap of NZ$18.99 Million. This makes CytoMed Therapeutics the world's 10301th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of CytoMed Therapeutics from 2023 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$18.99 M-38.73%
2025NZ$30.99 M-47.58%
2024NZ$59.13 M-33.8%
2023NZ$89.33 M

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of CytoMed Therapeutics was reported to be:

NZ$18.78 Million
by Nasdaq info icon info icon
NZ$19.09 Million
by CompaniesMarketCap info icon info icon